| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A L Barkan, R P Kelch, N J Hopwood, I Z Beitin. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. The Journal of clinical endocrinology and metabolism. vol 66. issue 1. 1988-02-02. PMID:2891720. |
treatment of acromegaly with the long-acting somatostatin analog sms 201-995. |
1988-02-02 |
2023-08-11 |
Not clear |
| A L Barkan, R P Kelch, N J Hopwood, I Z Beitin. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. The Journal of clinical endocrinology and metabolism. vol 66. issue 1. 1988-02-02. PMID:2891720. |
fifteen patients with active acromegaly (8 previously treated and 7 newly diagnosed) were treated with the long-acting somatostatin analog sms 201-995 (sandoz; 50-250 micrograms, sc, every 6-8 h for up to 21 months). |
1988-02-02 |
2023-08-11 |
Not clear |
| M E Geffner, R A Nagel, R B Dietrich, S A Kapla. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. The Journal of pediatrics. vol 111. issue 5. 1987-12-14. PMID:2889819. |
treatment of acromegaly with a somatostatin analog in a patient with mccune-albright syndrome. |
1987-12-14 |
2023-08-11 |
Not clear |
| S R George, K Kovacs, S L Asa, E Horvath, E G Cross, G N Burro. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma. Clinical endocrinology. vol 26. issue 4. 1987-11-19. PMID:2888549. |
it appears that sms 201-995 represents a potent and promising drug in the medical treatment of acromegaly, however, more work is needed to elucidate the mechanism of somatostatin suppression and to provide evidence for adenoma shrinkage. |
1987-11-19 |
2023-08-11 |
Not clear |
| J Timsit, P Chanson, E Larger, M Duet, A Mosse, P J Guillausseau, A G Harris, M Moulonguet, A Warnet, J Lubetzk. The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly. Acta endocrinologica. vol 116. issue 1. 1987-11-10. PMID:2889306. |
the effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (sms 201-995) on the diurnal gh profile in acromegaly. |
1987-11-10 |
2023-08-11 |
Not clear |
| J Timsit, P Chanson, E Larger, M Duet, A Mosse, P J Guillausseau, A G Harris, M Moulonguet, A Warnet, J Lubetzk. The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly. Acta endocrinologica. vol 116. issue 1. 1987-11-10. PMID:2889306. |
multiple sc injections of a long-acting somatostatin analogue (sms 201-995) are currently used in the treatment of acromegaly. |
1987-11-10 |
2023-08-11 |
Not clear |
| S R George, R A Hegele, G N Burro. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones. Clinical and investigative medicine. Medecine clinique et experimentale. vol 10. issue 4. 1987-10-27. PMID:2888554. |
the somatostatin analogue sms 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones. |
1987-10-27 |
2023-08-11 |
Not clear |
| R Horikawa, K Takano, N Hizuka, K Asakawa, T Shibasaki, A Masuda, K Shizum. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly. Endocrinologia japonica. vol 33. issue 6. 1987-06-26. PMID:2884093. |
effect of a single administration of somatostatin analogue (sms 201-995) on gh, tsh and insulin secretion in patients with acromegaly. |
1987-06-26 |
2023-08-11 |
Not clear |
| R Horikawa, K Takano, N Hizuka, K Asakawa, T Shibasaki, A Masuda, K Shizum. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly. Endocrinologia japonica. vol 33. issue 6. 1987-06-26. PMID:2884093. |
our results show that the new somatostatin analogue sms 201-995 may inhibit gh hypersecretion in acromegalic patients for significant periods, suggesting that this agent can be a useful clinical tool for the treatment of acromegaly. |
1987-06-26 |
2023-08-11 |
Not clear |
| G F Pieters, A E Smals, A G Smals, J A von Gennep, P W Kloppenbor. The effect of minisomatostatin on anomalous growth hormone responses in acromegaly. Acta endocrinologica. vol 114. issue 4. 1987-06-10. PMID:2883797. |
twelve patients with active acromegaly were treated with the long-acting somatostatin analogue sms 201-995 at a dose of 50 micrograms sc twice daily in the first 2 weeks of treatment and 100 micrograms twice daily thereafter. |
1987-06-10 |
2023-08-11 |
Not clear |
| P G Chiodini, R Cozzi, D Dallabonzana, G Oppizzi, G Verde, M Petroncini, A Liuzzi, E del Poz. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine. The Journal of clinical endocrinology and metabolism. vol 64. issue 3. 1987-03-31. PMID:2880861. |
medical treatment of acromegaly with sms 201-995, a somatostatin analog: a comparison with bromocriptine. |
1987-03-31 |
2023-08-11 |
Not clear |
| L M Sandler, J M Burrin, G Williams, G F Joplin, D H Carr, S R Bloo. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clinical endocrinology. vol 26. issue 1. 1987-03-19. PMID:2879656. |
effective long-term treatment of acromegaly with a long-acting somatostatin analogue (sms 201-995). |
1987-03-19 |
2023-08-11 |
Not clear |
| L Verschoor, S W Lamberts, P Uitterlinden, E Del Poz. Glucose tolerance during long term treatment with a somatostatin analogue. British medical journal (Clinical research ed.). vol 293. issue 6558. 1987-02-19. PMID:2878704. |
seven patients with active acromegaly were treated with sms 201-995, an analogue of somatostatin, for one year, the maximum dose being 100 micrograms three times a day. |
1987-02-19 |
2023-08-11 |
Not clear |
| L Verschoor, S W Lamberts, P Uitterlinden, E Del Poz. Glucose tolerance during long term treatment with a somatostatin analogue. British medical journal (Clinical research ed.). vol 293. issue 6558. 1987-02-19. PMID:2878704. |
this analogue of somatostatin had only minor side effects on glucose tolerance in patients with acromegaly and may be used in patients with impaired glucose tolerance provided that glucose concentrations are monitored closely. |
1987-02-19 |
2023-08-11 |
Not clear |
| S W Lamberts, M Zweens, J G Klijn, C C van Vroonhoven, S Z Stefanko, E Del Poz. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:2878748. |
the sensitivity of growth hormone and prolactin secretion to the somatostatin analogue sms 201-995 in patients with prolactinomas and acromegaly. |
1987-02-05 |
2023-08-11 |
Not clear |
| I M Jackson, L B Barnard, P Lamberto. Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly. The American journal of medicine. vol 81. issue 6B. 1987-02-04. PMID:2879453. |
role of a long-acting somatostatin analogue (sms 201-995) in the treatment of acromegaly. |
1987-02-04 |
2023-08-11 |
human |
| I M Jackson, L B Barnard, P Lamberto. Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly. The American journal of medicine. vol 81. issue 6B. 1987-02-04. PMID:2879453. |
the beneficial effect of the long-acting analogue of somatostatin sms 201-995 in the treatment of acromegaly is described in three cases, and current published experience is reviewed. |
1987-02-04 |
2023-08-11 |
human |
| R J Comi, P Gorde. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 1. 1987-01-16. PMID:2878009. |
the response of serum growth hormone levels to the long-acting somatostatin analog sms 201-995 in acromegaly. |
1987-01-16 |
2023-08-11 |
Not clear |
| G G Verde, I Santi, P Chiodini, R Cozzi, D Dallabonzana, G Oppizzi, A Liuzz. Serum type III procollagen propeptide levels in acromegalic patients. The Journal of clinical endocrinology and metabolism. vol 63. issue 6. 1986-12-29. PMID:2878008. |
since in acromegaly there is increased collagen production, we measured serum piiip in acromegalic patients before any treatment (basal), during medical treatment with the somatostatin analog sms 201-995, and after pituitary adenomectomy. |
1986-12-29 |
2023-08-11 |
human |
| L B Barnard, W G Grantham, P Lamberton, T M O'Dorisio, I M Jackso. Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995). Annals of internal medicine. vol 105. issue 6. 1986-12-11. PMID:2877605. |
treatment of resistant acromegaly with a long-acting somatostatin analogue (sms 201-995). |
1986-12-11 |
2023-08-11 |
Not clear |